Generation and properties of a human immunodeficiency virus type I isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)

被引:133
作者
Marozsan, AJ
Kuhmann, SE
Morgan, T
Herrera, C
Rivera-Troche, E
Xu, S
Baroudy, BM
Strizki, J
Moore, JP
机构
[1] Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
[2] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
关键词
HIV-1; CCR5; inhibitors; SCH-D; drug resistance; escape mutants;
D O I
10.1016/j.virol.2005.04.035
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We describe the generation of two genetically related human immunodeficiency virus type 1 (HIV-1) isolates highly (>20,000-fold) resistant to the small molecule CCR5 inhibitor, SCH-417690 (formerly SCH-D). Both viruses were cross-resistant to other small molecules targeting entry via CCR5, but they were inhibited by some MAbs against the same coreceptor on primary CD4(+) T-cells. The resistant isolates remained sensitive to inhibitors of other stages of virus entry, and to replication inhibitors acting post-entry. Neither escape mutant could replicate delectably in peripheral blood mononuclear cells (PBMC) from two donors homozygous for the CCR5-Delta 32 allele and both were insensitive to the CXCR4-specific inhibitor, AMD3100. Hence, the SCH-D escape mutants retained the R5 phenotype. One of the resistant isolates was, however, capable of replication in U87.CD4.CXCR4 cells and, after expansion in those cells, was sensitive to AMD3100 in primary CD4(+) T-cells. Hence, some X4 variants may be present in this escape mutant swarm. A notable observation was that the SCH-D escape mutants were also cross-resistant to PSC-RANTES and AOP-RANTES, chemokine derivatives that are reported to down-regulate cell surface CCR5 almost completely. However, the extent to which CCR5 is down-regulated was dependent upon the detection MAb. Hence, the escape mutants may be using a CCR5 configuration that is only detected by some anti-CCR5 MAbs. Finally, two SCH-D-resistant clonal viruses revealed no amino acid changes in the gp120 V3 region relative to the parental viruses, in marked contrast to clones resistant to the AD101 small molecule CCR5 inhibitor that possess 4 such sequence changes. Several sequence changes elsewhere in gp120 (V2, C3 and V4) were present in the SCH-D-resistant clones. Their influence on the resistant phenotype remains to be determined. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:182 / 199
页数:18
相关论文
共 68 条
[1]   Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7 [J].
Aarons, EJ ;
Beddows, S ;
Willingham, T ;
Wu, LJ ;
Koup, RA .
VIROLOGY, 2001, 287 (02) :382-390
[2]   Inhibiting HIV-1 entry with fusion inhibitors [J].
Baldwin, CE ;
Sanders, RW ;
Berkhout, B .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (17) :1633-1642
[3]   Antigenically distinct conformations of CXCR4 [J].
Baribaud, F ;
Edwards, TG ;
Sharron, M ;
Brelot, A ;
Heveker, N ;
Price, K ;
Mortari, F ;
Alizon, M ;
Tsang, M ;
Doms, RW .
JOURNAL OF VIROLOGY, 2001, 75 (19) :8957-8967
[4]   The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitors [J].
Billick, E ;
Seibert, C ;
Pugach, P ;
Ketas, T ;
Trkola, A ;
Endres, MJ ;
Murgolo, NJ ;
Coates, E ;
Reyes, GR ;
Baroudy, BM ;
Sakmar, TP ;
Moore, JP ;
Kuhmann, SE .
JOURNAL OF VIROLOGY, 2004, 78 (08) :4134-4144
[5]  
Bjorndal A, 1997, J VIROL, V71, P7478
[6]   Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies [J].
Blanpain, C ;
Vanderwinden, JM ;
Cihak, J ;
Wittamer, V ;
Le Poul, E ;
Issafras, H ;
Stangassinger, M ;
Vassart, G ;
Marullo, S ;
Schlöndorff, D ;
Parmentier, M ;
Mack, M .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (02) :723-737
[7]   Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1 [J].
Carnec, X ;
Quan, L ;
Olson, WC ;
Hazan, U ;
Dragic, T .
JOURNAL OF VIROLOGY, 2005, 79 (03) :1930-1933
[8]   Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells [J].
Carrillo, A ;
Ratner, L .
JOURNAL OF VIROLOGY, 1996, 70 (02) :1310-1316
[9]   Structure of an unliganded simian immunodeficiency virus gp120 core [J].
Chen, B ;
Vogan, EM ;
Gong, HY ;
Skehel, JJ ;
Wiley, DC ;
Harrison, SC .
NATURE, 2005, 433 (7028) :834-841
[10]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628